Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Notable movers of interest: MNST +15.4% on Q4 revenue beat<p>The following are some of today's most notable movers of interest, categorized by market capitalization (large cap over $10 billion and mid cap between $2-10 billion) and ranked by % change (all stocks over 100K average daily volume).</p><p><strong>Large Cap Gainers</strong></p><ul><li><strong>MNST</strong> (48.46 +15.35%): Shares rise on Q4 revenue beat.</li><li><strong>JD</strong> (31.83 +3.78%): Reports Q4 EPS and revenue beats; guides Q1 revs in-line.</li><li><strong>AVGO</strong> (219.24 +1.91%): Reports Q1 EPS and revenue beats; guides Q2 revs above consensus.</li></ul><p><strong>Large Cap Losers</strong></p><ul><li><strong>ABEV</strong> (5.5 -4.43%): Shares fall on Q4 revenue miss.</li><li><strong>KR</strong> (30.79 -3.96%): Shares fall after missing comp estimates for the 4th straight quarter.</li><li><strong>BUD</strong> (106.79 -2.87%): Reports Q4 EPS miss.</li></ul><p><strong>Mid Cap Gainers</strong></p><ul><li><strong>ACIW</strong> (21.94 +11.31%): Reports Q4 revenue beat.</li><li><strong>EXAS</strong> (23.44 +5.82%): Co and Mayo Clinic study shows promise of new blood-based lung cancer test.</li><li><strong>BURL</strong> (92.74 +4.58%): Reports Q4 EPS and revenue beats; guides FY18 EPS and revenues above consensus.</li></ul><p><strong>Mid Cap Losers</strong></p><ul><li><strong>GEF</strong> (52.96 -12.19%): Shares fall on Q1 EPS miss.</li><li><strong>OPK</strong> (7.62 -8.96%): Reports Q4 revenue miss.</li><li><strong>VGR</strong> (21.79 -6%): Reports Q4 EPS miss.</li></ul></td> </tr></table>"